Cognition Clinical Trial
Official title:
Collection of Normative Data for iPad-Based Cognitive Assessment Tools
NCT number | NCT03206775 |
Other study ID # | STUDY00000319 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 6, 2017 |
Est. completion date | March 25, 2019 |
Verified date | February 2020 |
Source | University of Minnesota |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Phase 1: This is a remote observational study in which participants will complete cognitive
assessments developed by Posit Science. Participants will be healthy controls aged 18-65 with
reliable internet access and a device that they can use to access the assessments, such as a
laptop or iPad. Participants will complete up to 6 Posit Science assessments in different
domains of cognition, which should last approximately 30 minutes.
Phase 2: This is an in person observational study in which participants will complete
cognitive assessments developed by Posit Science. Participants will be healthy controls aged
18-80 who are fluent in English. Participants will complete batteries of cognitive
assessments developed by Posit Science, which include combinations of visual, auditory, and
social cognitive assessments, and self-report questionnaires. This study will be conducted at
the Driven to Discover building at the Minnesota State Fair. Participation will last
approximately 20 minutes.
Phase 3: Participants in Phase 3 will complete a Posit Science assessment battery and
self-report questionnaires. Each participant will be asked to provide brief demographic and
medical history data. Participants will be aged 18-35 and will be students at the University
of Minnesota who are enrolled in the Research Experience Points program. Participants will
complete the assessment battery remotely; the battery will take approximately 45-60 minutes
to complete.
Phase 4: This is a pilot program to test the use of remote cognitive assessment and training
in adolescents with an anxiety diagnosis and healthy controls. Participants will complete a
short assessment battery, then will receive 4 hours of cognitive training over 2 weeks at
home. Then they will repeat the battery. Total participation should last approximately 5
hours over 2-3 weeks and will be completed entirely remotely.
Status | Completed |
Enrollment | 1271 |
Est. completion date | March 25, 2019 |
Est. primary completion date | March 25, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 80 Years |
Eligibility |
Phase 1 Inclusion Criteria: - Aged 18-65 - Willing and able to provide informed consent as determined by the REDCap assessment - Fluent in English (learned before the age of 12) - Has reliable internet access and a device such as a laptop or iPad which can be used to connect to the BrainHQ portal in a quiet place free of distraction - Able to use an iPad or computer to perform visual and auditory cognitive assessments unassisted - No history of schizophrenia, bipolar disorder with psychosis, or schizoaffective disorder - No neurological disorder, major head injury, mental retardation diagnosis, or autism spectrum disorder - Pregnant women may participate in this study Phase 2 Inclusion Criteria: - Aged 18-80 - Willing and able to provide informed consent - Learned English before the age of 12 - Pregnant women may participate in this study - Able to use an iPad to perform visual and/or auditory cognitive assessments unassisted. Phase 3 Inclusion Criteria: - Aged 18-35 - Willing and able to provide informed consent Fluent in English Able to use an iPad or computer to perform visual and auditory cognitive assessments unassisted - Has reliable internet access and a device such as a laptop or iPad which can be used to connect to the REDCap server and BrainHQ portal in a quiet place free of distraction Phase 4 Inclusion Criteria: - Aged 12-18 - Either has no mental health diagnosis (healthy control) or is diagnosed with an anxiety disorder - Willing and able to provide assent; at least one parent or guardian is able to provide written consent for participation - Fluent in English - Consistent access to a device with the iOS operating system (e.g., iPhone, iPad) - Able to use an iOS device to perform visual and auditory cognitive assessments unassisted - Has reliable internet access in a quiet place free from distraction to complete study activities Exclusion Criteria for all participants: - Unable or unwilling to provide informed consent - Not fluent in written/spoken English - Unable to use an iPad or computer to complete visual and/or auditory cognitive assessments without assistance - Presence of a medical or behavioral condition that would prohibit participation in the trial - Participant has used illicit substances or alcohol within the past 8 hours |
Country | Name | City | State |
---|---|---|---|
United States | University of Minnesota, Dept of Psychiatry | Minneapolis | Minnesota |
United States | University of California San Francisco | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of Minnesota | Posit Science Corporation, University of California, San Francisco |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visual Sweeps | Phase 1: Participants watch two spatial frequency sweeps and determine whether each one swept inward or outward | 4 minutes | |
Primary | Sustained Visual Attention | Phase 1: Participants are asked to press the spacebar as fast as they can whenever a star appears at the top of the screen (don't press when it appears at the bottom of the screen) | 4 minutes | |
Primary | Associative Learning--Visual | Phase 1: Participants will see a ring of items. They are asked to memorize the items and their locations. | 4 minutes | |
Primary | Associative Learning--Auditory | Phase 1: Participants will hear a sequence of syllables. They are asked to memorize the syllables and repeat the sequence by clicking on the words. | 4 minutes | |
Primary | Emotion Motion | Phase 1: Participants will see a video of a person showing a facial expression on every trial. They are asked to select the correct emotion | 4 Minutes | |
Primary | Voice Choice | Phase 1: A sentence spoken in a certain prosody will be presented on every trial. Correctly choose the emotion expressed in the sentence | 4 Minutes | |
Primary | On Trails: Learning | Phase 2, Battery A: Participants see two circles connected by paths. Remember the path from A to B, and click the circles in the order indicated. If the participant makes a mistake, the path is shown again. | 4 minutes | |
Primary | Line Length Discrimination | Phase 2, Battery A: Participants watch two lines surrounded by stars and determine which one is longer. | 4 minutes | |
Primary | Tap the Emotion | Phase 2, Battery A: This is an executive function go/no-go task that captures both inhibitory control and sustained attention abilities. Participants see a series of faces, each presented for a limited time. Participants are instructed to tap the button every time they see a happy or sad face, and to not tap the button when they see a neutral face | 4 minutes | |
Primary | Sound Sweeps | Phase 2, Battery A: Participants are presented with two subsequent tones that eithe rrise or lower in pitch, and they are asked to identify the direction of the pitch change. | 4 minutes | |
Primary | Visual Time Order Judgment | Phase 2, Battery B: Watch two visual patterns shown one after the other and determine which one was presented first | 4 minutes | |
Primary | Target Tracker | Phase 2, Battery B: Keep track of the targets as all the objects (targets and distractors) move around the screen. | 4 minutes | |
Primary | Emotional Face | Phase 2, Battery B: This is an emotional stroop task that provides a measure of executive attention. In each trial, an expressive face is shown and overlaid with a congruent or incongruent word (stroop effect). Participants see a series of faces, each presented for a limited time. Identify the emotion of the face as quickly as possible. If the face is displaying happiness, tap the HAPPY button. If the face is displaying fear, tap the FEAR button. Increased reaction time to incongruent stimulus combinations capture capacity for conflict resolution. | 4 minutes | |
Primary | Auditory Sound Discrimination | Phase 2, Battery B: Participants must determine which of two similar sounding syllable phonemes were spoken. | 4 minutes | |
Primary | Stroop 2AFC | Phase 2, Battery C: The name of a color written in colored text appears in the screen. Participants elect the color of the text by tapping left/right keyboard arrow as quickly as they can. | 4 minutes | |
Primary | Visual Task Switcher | Phase 2, Battery C: Two shapes are presented rapidly on the screen. Respond quickly if the two shapes share the same criteria, which changes from trial to trial (e.g., color). | 4 minutes | |
Primary | Beep Seeker | Phase 2, Battery C: Participants are presented with a target beep tone and then asked to identify it in the presence of distracting tones. | 4 minutes | |
Primary | Voice Choice | Phase 2, Battery C: A sentence spoken in a certain prosody will be presented on every trial. Correctly choose the emotion expressed in the sentence | 4 minutes | |
Secondary | Behavioral Inhibition Scale/Behavioral Activation Scale (BIS/BAS) | Participants will answer self-report questions to determine behavioral inhibition and behavioral activation. The scale is set at 1-4 1 not active at all and 5 being the most active | 4 minutes | |
Secondary | Temporal Experience of Pleasure Scale (TEPS) | Participants will answer self-report questions to determine their anticipatory and consummatory pleasure. Scale range is 1-6 1 being least pleasurable and 6 being the most pleasurable | 4 minutes | |
Secondary | Feasibility ratings | Participants will answer self report questions about the accessibility of the Posit Science cognitive assessments. | 1 minute |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04540523 -
Home-Based Exergaming Intervention
|
N/A | |
Suspended |
NCT01212029 -
Testing and Calibration of Non-Invasive Optical Imaging Technology for Functional Brain Imaging
|
N/A | |
Enrolling by invitation |
NCT05273970 -
Electrochemical and Electrophysiological Study
|
N/A | |
Recruiting |
NCT05227352 -
Bio-Experiential Spaces for Mental Health in Healthworkers
|
N/A | |
Completed |
NCT02671149 -
The Effect of Small Changes in Hydration on Cognition
|
N/A | |
Completed |
NCT01333306 -
Enhancing Cognitive Training Using tDCS
|
Phase 1 | |
Recruiting |
NCT05542199 -
Nutrition for Brain and Body Health (BB-Health) Feasibility Trial
|
N/A | |
Recruiting |
NCT06331286 -
The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
|
N/A | |
Recruiting |
NCT06254638 -
Effectiveness of a Multicomponent Intervention to Promote Physical Activity Levels During the School Day (MOVESCHOOL)
|
N/A | |
Completed |
NCT05998096 -
A Randomized Study to Examine the Ability of a Caffeine-Based Energy Drink to Impact Energy Expenditure, Fat Oxidation, Reaction Time, and Other Perceptual Indicators
|
N/A | |
Withdrawn |
NCT03224559 -
Applying Neuromodulation to Accelerate Training Effects
|
||
Completed |
NCT03129048 -
Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults
|
N/A | |
Recruiting |
NCT05394363 -
Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
|
||
Suspended |
NCT05107947 -
Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian Rhythm
|
N/A | |
Recruiting |
NCT05372172 -
Tennessee Alzheimer's Project
|
||
Recruiting |
NCT05132517 -
Magnesium and Cognition After Stroke
|
||
Recruiting |
NCT05992571 -
Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity
|
N/A | |
Recruiting |
NCT06097182 -
Postbiotic Intervention for Acute Stress Management
|
N/A | |
Completed |
NCT01223404 -
Nicotinic Modulation of the Default Network
|
N/A | |
Completed |
NCT00687102 -
Cognition in the Study of Tamoxifen and Raloxifene
|
Phase 3 |